Paclitaxel/ramucirumabAnorexia and hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1834卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87406-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：214 / 214

相关论文

共 50 条

[31] Azathioprine/paclitaxel/prednisoneVarious toxicities: 2 case reports
Reactions Weekly, 2021, 1841 (1) : 50 - 50
[32] Gefitinib/paclitaxel/pembrolizumabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1953 (1) : 196 - 196
[33] Cetuximab/paclitaxel/tacrolimusVarious toxicities: 2 case reports
Reactions Weekly, 2017, 1678 (1) : 55 - 55
[34] Paclitaxel/phenoxymethylpenicillin potassiumHaemophilia A in elderly patients (first report for paclitaxel): 2 case reports
Reactions Weekly, 2010, 1321 (1) : 26 - 26
[35] Lobaplatin/Paclitaxel/PembrolizumabLack of efficacy and death: 2 case reports
Reactions Weekly, 2025, 2048 (1) : 226 - 226
[36] BevacizumabEpistaxis, hypertension and thrombocytopenia: 2 case reports
Reactions Weekly, 2020, 1789 (1) : 64 - 64
[37] Paclitaxel/trastuzumabAllergic reaction and heart failure: 2 case reports
Reactions Weekly, 2014, 1500 (1) : 30 - 30
[38] BevacizumabFatigue and exacerbation of hypertension: 2 case reports
Reactions Weekly, 2018, 1721 (1) : 61 - 61
[39] CiclosporinHirsutism and hypertension in children: 2 case reports
Reactions Weekly, 2016, 1586 (1) : 84 - 84
[40] DasatinibPulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2023, 1979 (1) : 147 - 147

← 1 2 3 4 5 →